SCHEMBL19976728

SCHEMBL19976728

CCC(C)N/C(=N/C(=O)c1ccc(Cl)c(F)c1)Nc1[nH]nc2cc(C(F)(F)F)ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 3/20 0.37
HDAC6 Q9UBN7 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
GSK3B P49841 2/20 0.34
MAPK1 P28482 4/20 0.34
MAP2K4 P45985 2/20 0.34
MAPK6 Q16659 2/20 0.34
MAPKAPK5 Q8IW41 1/20 0.34
PTGER4 P35408 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
IDO1 P14902 1/20 0.33
KCNH2 Q12809 1/20 0.33
PPARG P37231 1/20 0.32
NTRK1 P04629 1/20 0.32
RET P07949 1/20 0.32
PDGFRB P09619 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976727 0.93 GSK3B (0.36) PTGESHDAC6MEN1KMT2AGSK3B
SCHEMBL19976798 0.91 PTGES (0.36) PTGESHDAC6MEN1KMT2ACYP3A4
SCHEMBL19976944 0.84 MAPK1 (0.36) KMT2AGSK3BMAPK1MAP2K4MAPK6
SCHEMBL19976928 0.81 CTNNB1 (0.37) PTGESKMT2AMAPK1ALDH1A1HTT
SCHEMBL17088632 0.78 GPR139 (0.37) HDAC6MAPK1IDO1KCNH2ALDH1A1
SCHEMBL19976851 0.77 POLB (0.35) KMT2AMAPK1MAP2K4MAPK6NPSR1
SCHEMBL19362702 0.77 RAB9A (0.39) MEN1KMT2AMAPK1NPSR1IDO1
SCHEMBL19362781 0.77 RAB9A (0.39) MEN1KMT2AMAPK1NPSR1IDO1
SCHEMBL19976829 0.77 HDAC6 (0.51) HDAC6GSK3BMAPK1MAP2K4MAPK6
SCHEMBL16771509 0.75 MEN1 (0.33) MEN1KMT2ACYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed